Yes, AI and ML are instrumental in accelerating the drug discovery process for cancer. Traditional drug discovery is a time-consuming and expensive process. AI can analyze vast datasets to identify potential drug candidates much faster. Machine learning algorithms can predict how different compounds will interact with cancer cells, thus narrowing down the list of potential drugs that need to be tested in clinical trials.